Metformin protects against ethanol-induced liver triglyceride accumulation by the LKB1/AMPK/ACC pathway
Authors:
- 22 June 2022
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (8) , 7837-7848
Abstract
Background Hepatic lipid accumulation is one of the main pathological features of alcoholic liver disease (ALD). Metformin serves as an AMPK activator and has been shown to have lipids lowering effects in non-alcoholic fatty liver disease (NAFLD), but its role in ALD remains unclear. The purpose of this study was to explore the potential mechanism of metformin regulating lipid metabolism in ALD. Methods and results In vitro and in vivo ALD models were established using AML12 cells and C57BL/6 mice, respectively. To determine the effect of metformin on ALD in vitro, the concentration of cellular triglyceride was examined by Nile red staining and a biochemical kit. To further reveal the role of metformin on ALD in vivo, liver tissues were examined by HE and oil red O staining, and the levels of ALT and AST in serum were determined via an automatic biochemical analyzer. The expression of mRNA and proteins were measured using qRT-PCR and Western blot, respectively. The role of the LKB1/AMPK/ACC axis on metformin regulating ethanol-induced lipid accumulation was evaluated by siRNA and AAV-shRNA interference. The results showed metformin reduced the ethanol-induced lipid accumulation in AML12 cells through activating AMPK, inhibiting ACC, reducing SREBP1c, and increasing PPARα. In addition, compared with control mice, metformin treatment inhibited ethanol-induced liver triglyceride accumulation and the increase of ALT and AST in serum. Interference with LKB1 attenuated the effect of metformin on ethanol-induced lipid accumulation both in vitro and in vivo. Conclusion Metformin protects against lipid formation in ALD by activating the LKB1/AMPK/ACC axis.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81900535)
- Natural Science Foundation of Fujian Province (2021J05038)
This publication has 35 references indexed in Scilit:
- The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung CancerMolecular Cell, 2018
- Treatment options for alcoholic and non-alcoholic fatty liver disease: A reviewWorld Journal of Gastroenterology, 2017
- Metformin – its potential anti-cancer and anti-aging effectsPostępy Higieny I Medycyny Doświadczalnej, 2017
- Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathwayAutophagy, 2014
- Involvement of Insulin Resistance in the Protective Effect of Metformin Against Alcoholic Liver InjuryAlcohol, Clinical and Experimental Research, 2014
- Mouse model of chronic and binge ethanol feeding (the NIAAA model)Nature Protocols, 2013
- Alcoholic Liver Disease: Pathogenesis and New Therapeutic TargetsGastroenterology, 2011
- Metformin for Obesity in Children and Adolescents: A Systematic ReviewDiabetes Care, 2009
- The role of AMP-activated protein kinase in the action of ethanol in the liverGastroenterology, 2004
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001